Article
Promoter Methylation of the Retinoic Acid Receptor Beta2 (RARβ2) Is Associated with Increased Risk of Breast Cancer: A PRISMA Compliant Meta-Analysis.
PloS one - 1 Jan 2015
Fang Cheng, Jian Zhi-Yuan, Shen Xian-Feng, Wei Xue-Mei, Yu Guo-Zheng, Zeng Xian-Tao
Abstract excerpt
BACKGROUND: Epigenetic studies demonstrate that an association may exist between methylation of the retinoic acid receptor beta2 (RARβ2) gene promoter and breast cancer onset risk, tumor stage, and histological grade, however the results of these studies are not consistent. Hence, we performed this meta-analysis to ascertain a more comprehensive and accurate association. MATERIALS AND METHODS: Relevant studies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
